Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 3/20 | 0.35 |
| ▸ | PPARA | Q07869 | 2/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP14 | P50281 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4611903 | 0.78 | CA1 (0.36) | SMN1; SMN2CA1CA2CA9KMT2A | |
| SCHEMBL27905117 | 0.78 | CA1 (0.48) | SMN1; SMN2CA1CA2CA9KMT2A | |
| SCHEMBL27779452 | 0.77 | CA1 (0.47) | SMN1; SMN2CA1CA2CA9KMT2A | |
| SCHEMBL14779309 | 0.76 | SMN1; SMN2 (0.51) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL776922 | 0.75 | CA1 (0.37) | SMN1; SMN2CA1CA2CA9ALDH1A1 | |
| SCHEMBL778362 | 0.75 | CA1 (0.45) | SMN1; SMN2CA1CA2CA9KMT2A | |
| SCHEMBL29092542 | 0.74 | CTRC (0.40) | CA1CA2CA9KMT2AALDH1A1 | |
| SCHEMBL1454240 | 0.72 | MTNR1A (0.49) | SMN1; SMN2POLBLMNAALDH1A1PPARG | |
| SCHEMBL10442793 | 0.72 | CA1 (0.45) | CA1CA2CA9KMT2ALMNA | |
| SCHEMBL4336610 | 0.72 | CA1 (0.45) | CA1CA2CA9KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7022823-B2 | Diazonium salt, its synthesizing method and recording material | FUJI PHOTO FILM CO., LTD. (JP) | 2006-04-04 | — | — | US | disclosed |
| US-20040039180-A1 | Diazonium salt, its synthesizing method and recording material | FUJI PHOTO FILM CO., LTD. | 2004-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039180-A1 | Diazonium salt, its synthesizing method and recording material | CACNA1E, HCN2, HCN1 | SMN1; SMN2 745/4885CA1 235/4885CA2 183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.